MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
批准号:
2896103
负责人:
ASTAR WINOTO
金额:
$21.94万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-05 至 2002-05-31
关键词:
CD95 molecule T lymphocyte apoptosis biological signal transduction chimeric proteins gene mutation gene targeting genetically modified animals immunoregulation laboratory mouse membrane proteins protein protein interaction protein structure function site directed mutagenesis tissue /cell culture transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Investigator's Abstract): The long term goal
of this proposed research is to understand the mechanisms of apoptosis in
malignant and primary T cells. Fas is a member of the tumor necrosis factor
receptor superfamily and is expressed on activated T cells and many
malignant cells. Treatment with anti-Fas antibody leads to apoptosis in
many but not all the tumor cells. A similar situation can also be found for
T cells from different developmental stages. Immature T cells is
particularly susceptible to Fas-induced apoptosis while mature T cells are
quite resistant to the apoptotic-effect of anti-Fas antibodies. Mort 1
/FADD is a protein with a death domain, a protein-protein interaction domain
that is also found in the cytoplasmic tail of Fas and tumor necrosis factor
receptor p55. In sensitive cells, addition of anti-Fas antibodies triggers
Mort1 to associate with Fas. Interference of this association process by a
dominant negative Mort1 protein leads to inhibition of apoptosis. In
several malignant cell lines that are resistant to Fas-mediated apoptosis,
Mortl was found not to associate with Fas. Thus, Mortl-Fas association is a
key step in Fas-induced apoptosis that might determine susceptibility of a
cell to anti-Fas-mediated cell death.
Lymphomas, thymomas and T cell hybridomas as well as transgenic and
gene-targeted mutant mice will be used to understand the role of Mortl in
apoptosis of malignant and primary T cells. The following specific aims are
proposed. First, structure-function analysis of the Mortl protein will be
performed using a Fas/Mortl chimeric protein. Second, the molecular process
of Mortl/Fas association will be examined in malignant and primary T cells.
Third, Mortl-deficient mice will be generated and analyzed. Fourth, the
role of Mort I and one of its associating protein in apoptosis of immature T
cells will be examined.
The above aims should lead to a better understanding of the mechanisms of
peripheral and central tolerance and why some tumor cells are resistant to
Fas-induced apoptosis. The information obtained might lead to means by
which apoptosis in resistant tumor cells might be induced and to halting of
the onset of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8997965
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8295838
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8436162
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
The role of Fas-associated death domain in necroptosis in vivo
-
批准号:8609544
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2012
-
负责人:ASTAR WINOTO
-
依托单位:
Transgenic/Knockout Mice
-
批准号:7081710
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2006
-
负责人:ASTAR WINOTO
-
依托单位:
Role of " Apoptotic proteins" Regulation Innate Immunity
-
批准号:7081706
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2006
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6927959
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6603117
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6359738
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6755891
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
TRAIL receptor in apoptosis and the immune system
-
批准号:6515156
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2001
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:2712889
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6604315
-
项目类别:
-
资助金额:$28.32万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:2377328
-
项目类别:
-
资助金额:$20.62万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:6376484
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6755892
-
项目类别:
-
资助金额:$28.3万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:7091541
-
项目类别:
-
资助金额:$27.57万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6904664
-
项目类别:
-
资助金额:$28.27万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
-
批准号:6173506
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
MORT1 in Apoptosis of Malignant and Primary T cells
-
批准号:6542008
-
项目类别:
-
资助金额:$28.25万
-
财政年份:1997
-
负责人:ASTAR WINOTO
-
依托单位:
海外基金